File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1478-3231.2009.02040.x
- Scopus: eid_2-s2.0-67650469849
- PMID: 19490415
- WOS: WOS:000267709300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Liver cancer stem cells: Implications for a new therapeutic target
Title | Liver cancer stem cells: Implications for a new therapeutic target | ||||
---|---|---|---|---|---|
Authors | |||||
Keywords | Bone marrow cells CSCs HCC Hepatocytes Oval cells | ||||
Issue Date | 2009 | ||||
Publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1478-3223&site=1 | ||||
Citation | Liver International, 2009, v. 29 n. 7, p. 955-965 How to Cite? | ||||
Abstract | Hepatocellular carcinoma (HCC) is an aggressive tumour with a poor prognosis. Current therapeutic strategies against this disease target mostly rapidly growing differentiated tumour cells. However, the result is often dismal due to the chemoresistant nature of this tumour type. Recent research efforts on stem cells and cancer biology have shed light on new directions for the eradication of cancer stem cells (CSCs) in HCC. The liver is a distinctive organ with the ability of tissue renewal in response to injury. Based on the hypothesis that cancer development is derived from the hierarchy of the stem cell system, we will briefly discuss the origin of liver stem cells and its relation to HCC development. We will also summarize the current CSC markers in HCC and discuss their relevance to the treatment of this deadly disease. © 2009 John Wiley & Sons A/S. | ||||
Persistent Identifier | http://hdl.handle.net/10722/88508 | ||||
ISSN | 2023 Impact Factor: 6.0 2023 SCImago Journal Rankings: 2.087 | ||||
ISI Accession Number ID |
Funding Information: Financial support: This study was funded by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C). | ||||
References | |||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, TKW | en_HK |
dc.contributor.author | Castilho, A | en_HK |
dc.contributor.author | Ma, S | en_HK |
dc.contributor.author | Ng, IOL | en_HK |
dc.date.accessioned | 2010-09-06T09:44:17Z | - |
dc.date.available | 2010-09-06T09:44:17Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | Liver International, 2009, v. 29 n. 7, p. 955-965 | en_HK |
dc.identifier.issn | 1478-3223 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/88508 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is an aggressive tumour with a poor prognosis. Current therapeutic strategies against this disease target mostly rapidly growing differentiated tumour cells. However, the result is often dismal due to the chemoresistant nature of this tumour type. Recent research efforts on stem cells and cancer biology have shed light on new directions for the eradication of cancer stem cells (CSCs) in HCC. The liver is a distinctive organ with the ability of tissue renewal in response to injury. Based on the hypothesis that cancer development is derived from the hierarchy of the stem cell system, we will briefly discuss the origin of liver stem cells and its relation to HCC development. We will also summarize the current CSC markers in HCC and discuss their relevance to the treatment of this deadly disease. © 2009 John Wiley & Sons A/S. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1478-3223&site=1 | en_HK |
dc.relation.ispartof | Liver International | en_HK |
dc.subject | Bone marrow cells | - |
dc.subject | CSCs | - |
dc.subject | HCC | - |
dc.subject | Hepatocytes | - |
dc.subject | Oval cells | - |
dc.subject.mesh | Animals | en_HK |
dc.subject.mesh | Antineoplastic Agents - therapeutic use | en_HK |
dc.subject.mesh | Carcinoma, Hepatocellular - drug therapy - metabolism - pathology | en_HK |
dc.subject.mesh | Cell Differentiation | en_HK |
dc.subject.mesh | Cell Proliferation | en_HK |
dc.subject.mesh | Drug Design | en_HK |
dc.subject.mesh | Hepatocytes - drug effects - metabolism - pathology | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Liver - drug effects - metabolism - pathology | en_HK |
dc.subject.mesh | Liver Neoplasms - drug therapy - metabolism - pathology | en_HK |
dc.subject.mesh | Liver Regeneration | en_HK |
dc.subject.mesh | Neoplastic Stem Cells - drug effects - metabolism - pathology | en_HK |
dc.subject.mesh | Signal Transduction | en_HK |
dc.subject.mesh | Stem Cells - drug effects - metabolism - pathology | en_HK |
dc.subject.mesh | Tumor Markers, Biological - metabolism | en_HK |
dc.title | Liver cancer stem cells: Implications for a new therapeutic target | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1478-3223&volume=29&spage=955&epage=965&date=2009&atitle=Liver+cancer+stem+cells:+Implications+for+a+new+therapeutic+target | en_HK |
dc.identifier.email | Lee, TKW:tkwlee@hkucc.hku.hk | en_HK |
dc.identifier.email | Ma, S:sma@pathology.hku.hk | en_HK |
dc.identifier.email | Ng, IOL:iolng@hkucc.hku.hk | en_HK |
dc.identifier.authority | Lee, TKW=rp00447 | en_HK |
dc.identifier.authority | Ma, S=rp00506 | en_HK |
dc.identifier.authority | Ng, IOL=rp00335 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/j.1478-3231.2009.02040.x | en_HK |
dc.identifier.pmid | 19490415 | - |
dc.identifier.scopus | eid_2-s2.0-67650469849 | en_HK |
dc.identifier.hkuros | 158604 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-67650469849&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 29 | en_HK |
dc.identifier.issue | 7 | en_HK |
dc.identifier.spage | 955 | en_HK |
dc.identifier.epage | 965 | en_HK |
dc.identifier.isi | WOS:000267709300001 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Molecular pathology of liver cancer - a multidisciplinary study | - |
dc.identifier.citeulike | 5110192 | - |
dc.identifier.issnl | 1478-3223 | - |